1. Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma
   Silvia Pomella et al, 2023, Cancers CrossRef
2. Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance
   Guo-Hua Li et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
3. Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
   Zhen-Chu Tang et al, 2023, Frontiers in Pharmacology CrossRef
4. Deregulation of enhancer structure, function, and dynamics in acute lymphoblastic leukemia
   Laura Belver et al, 2021, Trends in Immunology CrossRef
5. Identification of super-enhancer-driven peptidyl arginine deiminases as potential biomarkers and therapeutic targets for osimertinib-resistant non-small cell lung cancer
   Hang Li et al, 2022, Frontiers in Pharmacology CrossRef
6. Superenhancers as master gene regulators and novel therapeutic targets in brain tumors
   Hai-Hui Zhuang et al, 2023, Experimental & Molecular Medicine CrossRef
7. Super Enhancer-Regulated LINC00094 (SERLOC) Upregulates the Expression of MMP-1 and MMP-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma
   Minna Piipponen et al, 2022, Cancers CrossRef
8. Polymeric Nanocomposites for Cancer-Targeted Drug Delivery
   Luiza Steffens Reinhardt et al, 2022, Polymeric and Natural Composites CrossRef
9. Targeting transcription cycles in cancer
   Stephin J. Vervoort et al, 2022, Nature Reviews Cancer CrossRef
10. A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer
    Qing Wu et al, 2023, BMC Cancer CrossRef
11. A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer
    Corina E. Antal et al, 2023, Nature Communications CrossRef